Amal Sabry Othman

Authors

  • Rama Rao Vunnam Faculty of Pharmacy, Dr. K. N Modi University, Newai, Rajasthan, India
  • Sriharsha S. N Faculty of Pharmacy, Mahathi College of Pharmacy, Madanapalle, Chittoor - Dist, AP
  • VV Rajesham Vijaya College of Pharmacy, Munaganoor (V), Hayathnagar (M), Hyderabad

Keywords:

Valsartan Metformin, Itopride, Gastroparesis, Diabetes mellitus, Pharmacokinetics

Abstract

Gastroparesis is a syndrome characterized by delayed gastric emptying, in the absence of mechanical obstruction of the stomach. Diabetes mellitus (DM) is responsible for almost one third of cases of gastroparesis. Gastroparesis typically develops after at least 10 years of evolution of DM, and often is associated with other complications. The present study aimed to investigate the safety, reliability of Metformin and possible drug interaction with Itopride when they were administered as combination treatment. The study was conducted on healthy Wistar and streptozotocin induced diabetic rats. A simple and sensitive high performance liquid chromatographic method was developed for the simultaneous estimation of Metformin and Itopride in rat plasma and also to estimate possible pharmacokinetic parameters of these drugs after oral administration. There was no significant difference in the Metformin alone and combination with Itopride and Itopride alone and combination with Metformin on day 1 and day 8 respectively. There is no significant change in tmax, c max, AUC (0 ă t) and AUC (o-inf), tó, Cl/f and V/f on day 1 and day 8 respectively in both diabetic and healthy rats. From the above results it can be concluded that the concurrent administration of these two drugs have potential benefit in the treatment of Diabetes and Gastroparesis. In addition, due to their insignificant pharmacokinetic interaction the combinational therapy can be safe and highly advantageous in Gastro paresis patients with diabetes

References

. Bastaki S. Diabetes mellitus and its treatment. Int. j . Diabetes and Metabolism. 2005; 13: 111-134.

. Murthy T, Mayuren C, Krishna M, Reddy T. Study of interaction between amlodipine besylate and gliclazide in healthy rats. Int J Pharm Biol Sci. 2008; 2: 139-42.

. Swami AM, Shetty SR, Kumar S, Rao N. A study on drug-drug interaction of roxithromycin and antidiabetic drugs. Indian Drugs. 2005; 42: 808-13.

. Satyanarayana S, Krishnaiah Y, Eswar Kumar K, Elisha Raj I, Kanti Kiran V. Influence of Quinidine, Selegiline and Amphotericin-B on the pharamacokinetics and pharmacodynamics of Tolbutamide in Rabbits. Indian drugs. 1998; 35: 640-4.

. Rambhimaiah S, Suresh D, Gupta V, Ravi Prakash P, Srinivas Rao P. Influence of metronidazole on the hypoglycaemic effect of tolbutamide in healthy albino rabbits. Indian drugs. 2003; 40: 535-8.

. Palmer KJ, Brogden RN. Gliclazide: An update of its pharmacological properties and therapeutic efficacy in non-insulin-dependent diabetes mellitus. Drugs. 1993; 46(1): 92-125.

. Kohler G, Bode-Boger S, Busse R, Hoopmann M, Welte T, Boger R.. Elements of clinical pharmacy, 6th edi. 2004. BS Shah Prakashan Ahmedbad.

. Pentikäinen P. Bioavailability of metformin. Comparison of solution, rapidly dissolving tablet, and three sustained release products. IJCPT. 1986; 24: 213-20.

. Heutling D, Schulz H, Nickel I, Kleinstein J, Kaltwasser P, Westphal S, Mittermayer F, Wolzt M, Krzyzanowska K, Randeva H. Asymmetrical dimethylarginine, inflammatory and metabolic parameters in women with polycystic ovary syndrome before and after metformin treatment. j clinical endocrinology metabolism. 2008; 93: 82-90.

. Scheen AJ. Clinical pharmacokinetics of metformin. Clin pharmacokinetics. 1996; 30: 359-71.

. Nagy CF, Kumar D, Perdomo CA, Wason S, Cullen EI, Pratt RD. Concurrent administration of donepezil HCl and sertraline HCl in healthy volunteers: assessment of pharmacokinetic changes and safety following single and multiple oral doses. Bri. j clin ph cology. 2004; 58: 25-33.

. Davit BM, Nwakama PE, Buehler GJ, Conner DP, Haidar SH, Patel DT, Yang Y, Lawrence XY, Woodcock J. Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration. Annals of Pharmacotherapy. 2009; 43: 1583-97.

. Meredith P. Bioequivalence and other unresolved issues in generic drug substitution. Clinical therapeutics. 2003; 25: 2875-90.

. Vunnam RR, Sriharsha S, Rajesham V. A new validated RP-HPLC method for simultaneous estimation of Itopride and Metformin HCl in bulk formulation. Der Pharmacia Lettre. 2014; 6 (6):76-81

Downloads

Published

2015-03-31

How to Cite

Rama Rao Vunnam, Sriharsha S. N, & VV Rajesham. (2015). Amal Sabry Othman. International Journal of Drug Delivery, 7(1), 52–59. Retrieved from https://ijdd.arjournals.org/index.php/ijdd/article/view/271

Issue

Section

Original Research Articles